L-Leucinamide, N-[(5-methyl-3-isoxazolyl)carbonyl]-L-al

L-Leucinamide, N-[(5-methyl-3-isoxazolyl)carbonyl]-L-al Chemische Eigenschaften,Einsatz,Produktion Methoden

• Definition

  ChEBI: N-[(5-methyl-1,2-oxazol-3-yl)carbonyl]-L-alanyl-L-valyl-N-{(2S,3E)-5-(benzyloxy)-5-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]pent-3-en-2-yl}-L-leucinamide is a tripeptide resulting from the formal condensation of the carboxy group of N-[(5-methyl-1,2-oxazol-3-yl)carbonyl]-L-alanyl-L-valine with the amino group of benzyl (2E,4S)-4-(L-leucylamino)-5-[(3S)-2-oxopyrrolidin-3-yl]pent-2-enoate. It is an inhibitor of the main protease of SARS-CoV-2. It has a role as an antiviral agent, an EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor and an anticoronaviral agent. It is a tripeptide, a member of isoxazoles, a member of pyrrolidin-2-ones and a benzyl ester.

• Lager

  Store at -20°C

L-Leucinamide, N-[(5-methyl-3-isoxazolyl)carbonyl]-L-al Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global(5)Suppliers